open access

Vol 80, No 10 (2009)
ARTICLES
Get Citation

RHD variant in RhD/-/ mother with anti-D makes noninvasive fetal RHD genotyping impossible

Anna Lipińska, Justyna Smolarczyk-Wodzyńska, Magdalena Łakomy, Karina Engel, Orzińska Agnieszka, Monika Pelc-Kłopotowska
Ginekol Pol 2009;80(10).

open access

Vol 80, No 10 (2009)
ARTICLES

Abstract

Abstract Objectives: Noninvasive fetal RHD genotyping from maternal plasma of RhD(/-) pregnant women of Caucasian race may be used for predicting the risk of hemolytic disease because the RHD gene is usually absent in such populations. If detected in plasma of such women, the RHD gene originates from the RhD(+) fetus. The number of fetal copies of the gene in maternal plasma is extremely small. In the presented case of the RhD(/-) pregnant woman with anti-D it was impossible to give a fetal RHD result due to mother’s RHD(+) genotype. The fetal RHD was determined from amniocytes. Aim: to present the difficulties related to the interpretation of results of invasive and noninvasive procedures. Material and methods: whole blood, plasma and amniotic fluid of the RhD(-) woman with anti-D (14 week of pregnancy) as well as whole blood of the newborn. RHD and RHCE*c were genotyped by real-time PCR in DNA isolated from maternal plasma and amniocytes and the RHD and d-genotypes were tested by SSP methods in DNA isolated from whole blood and amniocytes . Results: RHD and RHCE*c were detected in DNA isolated from plasma. The high level of RHD suggested its origin from the mother’s DNA therefore it was impossible to determine the fetal RHD. The d-little test identified a RHD(IVS3+1G>A) variant in the mother’s genome. A weak signal of real-time PCR for the RHD was obtained in amniocytes but the RHD was not detected by SSP. The RHCE*c was detected by both methods. Results were inconclusive; the fetal RHD status remained unknown. The child was RhD(-) with RHD in its DNA undetected by either method. Conclusions: 1/ The RHD(IVS3+1G>A) variant in the RhD(-) mother precluded formal noninvasive fetal RHD genotyping. 2/Real-time PCR is too sensitive for amniocyte testing and may lead to false results as it detects trace maternal DNA in amniotic fluid 3/ The frequency of RHD(IVS3+1G>A) occurrence in Poland requires further studies.

Abstract

Abstract Objectives: Noninvasive fetal RHD genotyping from maternal plasma of RhD(/-) pregnant women of Caucasian race may be used for predicting the risk of hemolytic disease because the RHD gene is usually absent in such populations. If detected in plasma of such women, the RHD gene originates from the RhD(+) fetus. The number of fetal copies of the gene in maternal plasma is extremely small. In the presented case of the RhD(/-) pregnant woman with anti-D it was impossible to give a fetal RHD result due to mother’s RHD(+) genotype. The fetal RHD was determined from amniocytes. Aim: to present the difficulties related to the interpretation of results of invasive and noninvasive procedures. Material and methods: whole blood, plasma and amniotic fluid of the RhD(-) woman with anti-D (14 week of pregnancy) as well as whole blood of the newborn. RHD and RHCE*c were genotyped by real-time PCR in DNA isolated from maternal plasma and amniocytes and the RHD and d-genotypes were tested by SSP methods in DNA isolated from whole blood and amniocytes . Results: RHD and RHCE*c were detected in DNA isolated from plasma. The high level of RHD suggested its origin from the mother’s DNA therefore it was impossible to determine the fetal RHD. The d-little test identified a RHD(IVS3+1G>A) variant in the mother’s genome. A weak signal of real-time PCR for the RHD was obtained in amniocytes but the RHD was not detected by SSP. The RHCE*c was detected by both methods. Results were inconclusive; the fetal RHD status remained unknown. The child was RhD(-) with RHD in its DNA undetected by either method. Conclusions: 1/ The RHD(IVS3+1G>A) variant in the RhD(-) mother precluded formal noninvasive fetal RHD genotyping. 2/Real-time PCR is too sensitive for amniocyte testing and may lead to false results as it detects trace maternal DNA in amniotic fluid 3/ The frequency of RHD(IVS3+1G>A) occurrence in Poland requires further studies.
Get Citation

Keywords

rhesus blood group, Immunization, polymerase chain reaction - PCR, prenatal diagnosis

About this article
Title

RHD variant in RhD/-/ mother with anti-D makes noninvasive fetal RHD genotyping impossible

Journal

Ginekologia Polska

Issue

Vol 80, No 10 (2009)

Bibliographic record

Ginekol Pol 2009;80(10).

Keywords

rhesus blood group
Immunization
polymerase chain reaction - PCR
prenatal diagnosis

Authors

Anna Lipińska
Justyna Smolarczyk-Wodzyńska
Magdalena Łakomy
Karina Engel
Orzińska Agnieszka
Monika Pelc-Kłopotowska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl